| BioID | bio2616 |
| Name | TEZOSENTAN |
| ChEMBL ID | CHEMBL61780 |
| Molecular Formula | C27H27N9O6S |
| Molecular Weight | 605.64 |
| Molecular Weight (Monoisotopic) | 605.1805 |
| Type | Small molecule |
| Max Phase | Phase 3 |
| Target ID | Tar12 |
| Target Name | Toll-like receptor 9 (TLR9) |
| Synonyms | ACT-050089|Ro 61-0612|Ro-610612|TEZOSENTAN|Tezosentan|Veletri |
| Smiles | COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)C)cn2)nc(-c2ccnc(-c3nnn[nH]3)c2)nc1OCCO |
| Inchi | InChI=1S/C27H27N9O6S/c1-16(2)18-8-9-22(29-15-18)43(38,39)34-26-23(42-21-7-5-4-6-20(21)40-3)27(41-13-12-37)31-24(30-26)17-10-11-28-19(14-17)25-32-35-36-33-25/h4-11,14-16,37H,12-13H2,1-3H3,(H,30,31,34)(H,32,33,35,36) |
| Inchi Key | TUYWTLTWNJOZNY-UHFFFAOYSA-N |
| Molecular Species | ACID |
| Targets | 7.0 |
| Bioactivities | 14.0 |
| Np Likeness Score | -1.13 |
| Records Key | ['tezosentan', 'TEZOSENTAN', 'Tezosentan', 'TEZOSENTAN', 'Tezosentan', '23'] |
| Records Name | ['5-Isopropyl-pyridine-2-sulfonic acid {6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-[2-(1H-tetrazol-5-yl)-pyridin-4-yl]-pyrimidin-4-yl}-amide', 'TEZOSENTAN', 'Tezosentan', 'TEZOSENTAN', 'Tezosentan', 'Tezosentan'] |
| Withdrawn Flag | False |
| Orphan | 0 |